Reed Friend

4PUBLICATIONS
30CO-AUTHORS
Haematological tumoursGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Apr 07, 2026
Beyond age: Frailty-guided care in hematologic malignancies.

Reed Friend, P Connor Johnson, Daphne Campbell

|Feb 20, 2026
Belantamab mafodotin, carfilzomib, lenalidomide, and dexamethasone for relapsed or refractory multiple myeloma.

Shebli Atrash, James Symanowski, Myra Robinson

|Aug 01, 2025
Sequential targeting in multiple myeloma: talquetamab, a GPRC5D bispecific antibody, as a bridge to BCMA CAR-T therapy.

Binod Dhakal, Othman S Akhtar, David Fandrei

|Nov 22, 2024
MRD-driven phase 2 study of daratumumab, carfilzomib, lenalidomide, and dexamethasone in newly diagnosed multiple myeloma.

Manisha Bhutani, Myra Robinson, David Foureau

Pageof 1

Frequent Collaborators

3 joint publications

Manisha Bhutani

2 joint publications

David M Foureau

2 joint publications

Shebli Atrash

2 joint publications

Mauricio Pineda-Roman